Advertisement

Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure

Published:September 24, 2022DOI:https://doi.org/10.1016/j.jjcc.2022.08.015

      Highlights

      • Hepato-renal dysfunction in heart failure (HF) patients affects prognosis.
      • Hepato-renal dysfunction is associated with frailty in patients with HF.
      • The elevated MELD-XI score was associated with the presence of frailty.
      • Hepato-renal dysfunction with frailty was related to poor prognosis in HF patients.

      Abstract

      Background

      Complex multi-organ interactions such as coexistence of hepato-renal dysfunction in heart failure (HF) adversely affects patient prognosis. However, the association between liver/kidney dysfunction and frailty and effects of their coexistence on HF prognosis remain unclear.

      Methods

      This retrospective cohort study included 922 patients with HF (median age, 72 years; interquartile range: 62–79 years). All patients underwent hepato-renal function testing using the model for end-stage liver disease, excluding international normalized ratio (MELD-XI) score and frailty score. Frailty was measured using a composite of four markers: handgrip strength, gait speed, serum albumin, and activities of daily living status, combined into a total frailty score (range 0–12). Patients were assigned to a frailty score <5 (without frailty) or ≥5 (frailty) group. The multivariable logistic regression model was used to analyze the association between MELD-XI score and frailty; the prognostic value of high MELD-XI score and frailty coexistence was investigated. The endpoint was all-cause mortality.

      Results

      After adjusting for covariates and dividing by the median MELD-XI score, the high MELD-XI score group [odds ratio: 1.663, 95 % confidence interval (CI): 1.200–2.304, p = 0.002] was significantly associated with frailty, compared with the low MELD-XI score group. One hundred and fifty deaths occurred during follow-up (median, 2.13 years; interquartile range, 0.93–4.09 years). Patients in the high MELD-XI score/frailty group had a significantly higher mortality risk, even after adjusting for HF severity (hazard ratio: 4.326, 95 % CI: 2.527–7.403, p < 0.001).

      Conclusions

      Hepato-renal dysfunction is associated with frailty in patients with HF, which affects patient prognosis.

      Brief summary

      This study showed that hepato-renal dysfunction in patients with HF, as assessed by the model for end-stage liver disease excluding international normalized ratio (MELD-XI) score, is associated with frailty, even after adjusting for factors involved in the frailty or severity of HF. Additionally, high MELD-XI score combined with frailty is associated with a poorer prognosis. These results suggest that hepato-renal dysfunction and frailty can be used for risk stratification in patients with HF.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zsilinszka R.
        • Mentz R.J.
        • DeVore A.D.
        • Eapen Z.J.
        • Pang P.S.
        • Hernandez A.F.
        Acute heart failure: alternatives to hospitalization.
        JACC Heart Fail. 2017; 5: 329-336
        • Zymliński R.
        • Sokolski M.
        • Biegus J.
        • Siwołowski P.
        • Nawrocka-Millward S.
        • Sokolska J.M.
        • et al.
        Multi-organ dysfunction/injury on admission identifies acute heart failure patients at high risk of poor outcome.
        Eur J Heart Fail. 2019; 21: 744-750
        • Biegus J.
        • Hillege H.L.
        • Postmus D.
        • Valente M.A.
        • Bloomfield D.M.
        • Cleland J.G.
        • et al.
        Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
        Eur J Heart Fail. 2016; 18: 830-839
        • Gheorghiade M.
        • Pang P.S.
        Acute heart failure syndromes.
        J Am Coll Cardiol. 2009; 53: 557-573
        • Xanthopoulos A.
        • Starling R.C.
        • Kitai T.
        • Triposkiadis F.
        Heart failure and liver disease: cardiohepatic interactions.
        JACC Heart Fail. 2019; 7: 87-97
        • Verbrugge F.H.
        • Dupont M.
        • Steels P.
        • Grieten L.
        • Malbrain M.
        • Tang W.H.W.
        • et al.
        Abdominal contributions to cardiorenal dysfunction in congestive heart failure.
        J Am Coll Cardiol. 2013; 62: 485-495
        • Hamazaki N.
        • Kamiya K.
        • Yamamoto S.
        • Nozaki K.
        • Ichikawa T.
        • Matsuzawa R.
        • et al.
        Associations between kidney function and outcomes of comprehensive cardiac rehabilitation in patients with heart failure.
        Clin Res Cardiol. 2021; 111: 253-263
        • Mentz R.J.
        • Kelly J.P.
        • von Lueder T.G.
        • Voors A.A.
        • Lam C.S.
        • Cowie M.R.
        • et al.
        Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
        J Am Coll Cardiol. 2014; 64: 2281-2293
        • Samsky M.D.
        • Patel C.B.
        • DeWald T.A.
        • Smith A.D.
        • Felker G.M.
        • Rogers J.G.
        • et al.
        Cardiohepatic interactions in heart failure: an overview and clinical implications.
        J Am Coll Cardiol. 2013; 61: 2397-2405
        • Bunchorntavakul C.
        • Reddy K.R.
        Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.
        Aliment Pharmacol Ther. 2020; 51: 64-77
        • Feng Z.
        • Zhao H.
        • Jiang Y.
        • He Z.
        • Sun X.
        • Rong P.
        • et al.
        Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
        Clin Nutr. 2020; 39: 3132-3139
        • Lai J.C.
        • Rahimi R.S.
        • Verna E.C.
        • Kappus M.R.
        • Dunn M.A.
        • McAdams-DeMarco M.
        • et al.
        Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study.
        Gastroenterology. 2019; 156: 1675-1682
        • Laube R.
        • Wang H.
        • Park L.
        • Heyman J.K.
        • Vidot H.
        • Majumdar A.
        • et al.
        Frailty in advanced liver disease.
        Liver Int. 2018; 38: 2117-2128
        • Kim M.S.
        • Kato T.S.
        • Farr M.
        • Wu C.
        • Givens R.C.
        • Collado E.
        • et al.
        Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.
        J Am Coll Cardiol. 2013; 61: 2253-2261
        • Kamath P.S.
        • Kim W.R.
        Advanced liver disease study group. The model for end-stage liver disease (MELD).
        Hepatology. 2007; 45: 797-805
        • Biegus J.
        • Demissei B.
        • Postmus D.
        • Cotter G.
        • Davison B.A.
        • Felker G.M.
        • et al.
        Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial.
        ESC Heart Fail. 2019; 6: 1188-1198
        • Biegus J.
        • Zymlinski R.
        • Sokolski M.
        • Siwolowski P.
        • Gajewski P.
        • Nawrocka-Millward S.
        • et al.
        Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
        Eur J Heart Fail. 2016; 18: 1518-1521
        • Grodin J.L.
        • Gallup D.
        • Anstrom K.J.
        • Felker G.M.
        • Chen H.H.
        • Tang W.H.W.
        Implications of alternative hepatorenal prognostic scoring systems in acute heart failure (from DOSE-AHF and ROSE-AHF).
        Am J Cardiol. 2017; 119: 2003-2009
        • Ho K.K.
        • Anderson K.M.
        • Kannel W.B.
        • Grossman W.
        • Levy D.
        Survival after the onset of congestive heart failure in Framingham heart study subjects.
        Circulation. 1993; 88: 107-115
        • Ando Y.
        • Ito S.
        • Uemura O.
        • Kato T.
        • Kimura G.
        • Nakao T.
        • et al.
        CKD clinical practice guidebook. The essence of treatment for CKD patients.
        Clin Exp Nephrol. 2009; 13: 191-248
        • Heuman D.M.
        • Mihas A.A.
        • Habib A.
        • Gilles H.S.
        • Stravitz R.T.
        • Sanyal A.J.
        • et al.
        MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
        Liver Transpl. 2007; 13: 30-37
        • Green P.
        • Woglom A.E.
        • Genereux P.
        • Daneault B.
        • Paradis J.M.
        • Schnell S.
        • et al.
        The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.
        JACC Cardiovasc Interv. 2012; 5: 974-981
        • Fried L.P.
        • Tangen C.M.
        • Walston J.
        • Newman A.B.
        • Hirsch C.
        • Gottdiener J.
        • et al.
        Frailty in older adults: evidence for a phenotype.
        J Gerontol A Biol Sci Med Sci. 2001; 56: M146-M156
        • Zhang Z.
        Multiple imputation with multivariate imputation by chained equation (MICE) package.
        Ann Transl Med. 2016; 4: 30
        • Borovac J.A.
        • Glavas D.
        • Susilovic Grabovac Z.
        • Supe Domic D.
        • Stanisic L.
        • D'Amario D.
        • et al.
        Right ventricular free wall strain and congestive hepatopathy in patients with acute worsening of chronic heart failure: a CATSTAT-HF Echo substudy.
        J Clin Med. 2020; 9: 1317
        • Scholfield M.
        • Schabath M.B.
        • Guglin M.
        Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial.
        J Card Fail. 2014; 20: 476-484
        • Ronco C.
        • Haapio M.
        • House A.A.
        • Anavekar N.
        • Bellomo R.
        Cardiorenal syndrome.
        J Am Coll Cardiol. 2008; 52: 1527-1539
        • Tanaka T.
        • Kavsur R.
        • Spieker M.
        • Iliadis C.
        • Metze C.
        • Horn P.
        • et al.
        Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair.
        Clin Res Cardiol. 2021; 110: 1947-1956
        • Pandey A.
        • Kitzman D.
        • Reeves G.
        Frailty is intertwined with heart failure: mechanisms, prevalence, prognosis, assessment, and management.
        JACC Heart Fail. 2019; 7: 1001-1011
        • Chowdhury R.
        • Peel N.M.
        • Krosch M.
        • Hubbard R.E.
        Frailty and chronic kidney disease: a systematic review.
        Arch Gerontol Geriatr. 2017; 68: 135-142
        • Roshanravan B.
        • Gamboa J.
        • Wilund K.
        Exercise and CKD: skeletal muscle dysfunction and practical application of exercise to prevent and treat physical impairments in CKD.
        Am J Kidney Dis. 2017; 69: 837-852
        • Sárközy M.
        • Kovács Z.Z.A.
        • Kovács M.G.
        • Gáspár R.
        • Szűcs G.
        • Dux L.
        Mechanisms and modulation of oxidative/nitrative stress in type 4 cardio-renal syndrome and renal sarcopenia.
        Front Physiol. 2018; 9: 1648
        • Kubo I.
        • Izawa K.P.
        • Kajisa N.
        • Ryu M.
        • Akasaka H.
        • Ogura A.
        • et al.
        Worsening renal function during hospitalization in elderly patients with heart failure: an independent factor of activities of daily living decline.
        Heart Vessels. 2021; 36: 76-84
        • Van Laethem C.
        • Bartunek J.
        • Goethals M.
        • Verstreken S.
        • Walravens M.
        • De Proft M.
        • et al.
        Chronic kidney disease is associated with decreased exercise capacity and impaired ventilatory efficiency in heart transplantation patients.
        J Heart Lung Transplant. 2009; 28: 446-452
        • Kachaamy T.
        • Bajaj J.S.
        • Heuman D.M.
        Muscle and mortality in cirrhosis.
        Clin Gastroenterol Hepatol. 2012; 10: 100-102
        • Sinclair M.
        • Gow P.J.
        • Grossmann M.
        • Angus P.W.
        Review article: sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions.
        Aliment Pharmacol Ther. 2016; 43: 765-777
        • Anand A.C.
        Nutrition and muscle in cirrhosis.
        J Clin Exp Hepatol. 2017; 7: 340-357
        • Williams F.R.
        • Berzigotti A.
        • Lord J.M.
        • Lai J.C.
        • Armstrong M.J.
        Review article: impact of exercise on physical frailty in patients with chronic liver disease.
        Aliment Pharmacol Ther. 2019; 50: 988-1000
        • Vitale C.
        • Uchmanowicz I.
        Frailty in patients with heart failure.
        Eur Heart J Suppl. 2019; 21: L12-L16
        • Chokshi A.
        • Cheema F.H.
        • Schaefle K.J.
        • Jiang J.
        • Collado E.
        • Shahzad K.
        • et al.
        Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.
        J Heart Lung Transplant. 2012; 31: 591-600